Principal Securities »

Oncolytics Biotech shares owned by Principal Securities

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Principal Securities from 13F filings

Historical chart of Principal Securities investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Principal Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Principal Securities

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.6k 3.0k 0.87

More positions owned by Principal Securities

Principal Exchange Traded Us Mega Cp Etf (USMC)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Goldman Sachs Etf Tr Marketbeta Us Eq (GSUS)
Principal Exchange Traded Prin U S Small (PSC)
Microsoft Corporation (MSFT)
Principal Exchange Traded Focused Blue Chi (BCHP)
Ishares Tr Rus 1000 Etf (IWB)
Amazon (AMZN)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Apple (AAPL)
Principal Exchange Traded Prnc Invt Grad (IG)
Principal Exchange Traded Prncpl Vlu Etf (PY)
Goldman Sachs Etf Tr Activebeta Int (GSIE)

View all positions for Principal Securities

Top funds holding Oncolytics Biotech

Seeds Investor
International Assets Investment Management
Morgan Stanley
Goldman Sachs Group
Citadel Advisors
Royal Bank of Canada
Commonwealth Equity Services
CIBC World Markets
Geode Capital Management
Long Focus Capital Management
SeaCrest Wealth Management
Brave Asset Management
Newman Dignan & Sheerar
National Bank Of Canada /fi/
Financial Advisory Corp

View all funds holding Oncolytics Biotech